Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
124,170,178
-
Share change
-
+8,275,859
-
Total reported value
-
$12,442,828,442
-
Put/Call ratio
-
132%
-
Price per share
-
$100.20
-
Number of holders
-
653
-
Value change
-
+$858,918,999
-
Number of buys
-
239
-
Number of sells
-
304
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q3 2025
As of 30 Sep 2025,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
653 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
124,170,178 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, JPMORGAN CHASE & CO, CITIGROUP INC, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, BNP PARIBAS FINANCIAL MARKETS, WELLS FARGO & COMPANY/MN, UBS Group AG, and BARCLAYS PLC.
This page lists
653
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.